Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction.

O'Connor CM, Mentz RJ, Cotter G, Metra M, Cleland JG, Davison BA, Givertz MM, Mansoor GA, Ponikowski P, Teerlink JR, Voors AA, Fiuzat M, Wojdyla D, Chiswell K, Massie BM.

Eur J Heart Fail. 2012 Jun;14(6):605-12. doi: 10.1093/eurjhf/hfs029. Epub 2012 Apr 25.

2.

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.

Am Heart J. 2008 Oct;156(4):662-73. doi: 10.1016/j.ahj.2008.04.030.

PMID:
18926148
3.

Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome.

Torre-Amione G, Milo-Cotter O, Kaluski E, Perchenet L, Kobrin I, Frey A, Rund MM, Weatherley BD, Cotter G.

J Card Fail. 2009 Oct;15(8):639-44. doi: 10.1016/j.cardfail.2009.04.001. Epub 2009 Jun 13.

PMID:
19786251
4.

Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.

Cotter G, Metra M, Weatherley BD, Dittrich HC, Massie BM, Ponikowski P, Bloomfield DM, O'Connor CM.

Cardiology. 2010;115(1):29-36. doi: 10.1159/000249280. Epub 2009 Oct 20.

PMID:
19844102
5.

Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Klein L, Massie BM, Leimberger JD, O'Connor CM, Piña IL, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators.

Circ Heart Fail. 2008 May;1(1):25-33. doi: 10.1161/CIRCHEARTFAILURE.107.746933.

6.

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

Ueland T, Dahl CP, Kjekshus J, Hulthe J, Böhm M, Mach F, Goudev A, Lindberg M, Wikstrand J, Aukrust P, Gullestad L.

Circ Heart Fail. 2011 Mar;4(2):145-52. doi: 10.1161/CIRCHEARTFAILURE.110.957332. Epub 2011 Jan 7.

7.

Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study.

Cotter G, Metra M, Davison BA, Senger S, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Milo O, Kobrin I, Rainisio M, McMurray JJ, Teerlink JR; VERITAS Investigators.

Eur J Heart Fail. 2014 Dec;16(12):1362-71. doi: 10.1002/ejhf.186. Epub 2014 Nov 5.

8.

Usefulness of serum albumin and serum total cholesterol in the prediction of hospital death in older patients with severe, acute heart failure.

Arques S, Roux E, Stolidi P, Gelisse R, Ambrosi P.

Arch Cardiovasc Dis. 2011 Oct;104(10):502-8. doi: 10.1016/j.acvd.2011.06.003. Epub 2011 Sep 9.

9.

A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program.

Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA; American Heart Association Get With the Guidelines-Heart Failure Program.

Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):25-32. doi: 10.1161/CIRCOUTCOMES.109.854877. Epub 2009 Dec 8.

10.

Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study.

Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O'connor C, Adams KF, Orlandi C, Gheorghiade M.

J Card Fail. 2007 Jun;13(5):360-4.

PMID:
17602982
11.

Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.

O'Connor CM, Whellan DJ, Wojdyla D, Leifer E, Clare RM, Ellis SJ, Fine LJ, Fleg JL, Zannad F, Keteyian SJ, Kitzman DW, Kraus WE, Rendall D, Piña IL, Cooper LS, Fiuzat M, Lee KL.

Circ Heart Fail. 2012 Jan;5(1):63-71. doi: 10.1161/CIRCHEARTFAILURE.111.963462. Epub 2011 Nov 23.

12.

The significance of serum urea and renal function in patients with heart failure.

Gotsman I, Zwas D, Planer D, Admon D, Lotan C, Keren A.

Medicine (Baltimore). 2010 Jul;89(4):197-203. doi: 10.1097/MD.0b013e3181e893ee.

13.

Risk stratification after hospitalization for decompensated heart failure.

Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF Jr, Gheorghiade M, O'Connor CM.

J Card Fail. 2004 Dec;10(6):460-6.

PMID:
15599835
14.

Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?

Weatherley BD, Milo-Cotter O, Felker GM, Uriel N, Kaluski E, Vered Z, O'Connor CM, Adams KF, Cotter G.

Fundam Clin Pharmacol. 2009 Oct;23(5):633-9. doi: 10.1111/j.1472-8206.2009.00697.x. Epub 2009 Jul 28.

PMID:
19656213
15.

A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure.

Myers J, Arena R, Dewey F, Bensimhon D, Abella J, Hsu L, Chase P, Guazzi M, Peberdy MA.

Am Heart J. 2008 Dec;156(6):1177-83. doi: 10.1016/j.ahj.2008.07.010. Epub 2008 Sep 16.

PMID:
19033016
16.

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.

Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O'Connor CM, She L, Yancy CW, Young J, Fonarow GC; OPTIMIZE-HF Investigators and Coordinators.

Eur Heart J. 2007 Apr;28(8):980-8. Epub 2007 Feb 19.

17.

[The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].

Zoghi M, Duygu H, Güngör H, Nalbantgil S, Yilmaz GM, Tülüce K, Ozerkan F, Akilli A, Akin M.

Anadolu Kardiyol Derg. 2008 Aug;8(4):255-9. Turkish.

18.

Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Coordinators.

J Am Coll Cardiol. 2008 Jul 29;52(5):347-56. doi: 10.1016/j.jacc.2008.04.028.

19.
20.

Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.

Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators.

Circulation. 2005 May 17;111(19):2454-60. Epub 2005 May 2.

Items per page

Supplemental Content

Write to the Help Desk